SLC25A18 and infective vaginitis: The trivalent vaccine containing herpes simplex virus type 2 (HSV-2) glycoproteins C, D, and E (gC2, gD2, gE2) produced in baculovirus and administered with CpG/alum as adjuvants protected guinea pigs against HSV-2 vaginal infection and proved to cross-protect against HSV-1 [92].